Allatostatin II

CAS No. 123374-34-5

Allatostatin II( —— )

Catalog No. M30270 CAS No. 123374-34-5

Inhibitors of juvenile hormone synthesis in insects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Allatostatin II
  • Note
    Research use only, not for human use.
  • Brief Description
    Inhibitors of juvenile hormone synthesis in insects.
  • Description
    Inhibitors of juvenile hormone synthesis in insects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    123374-34-5
  • Formula Weight
    1067.2
  • Molecular Formula
    C49H74N14O13
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    Sequence:{Gly}{Asp}{Gly}{Arg}{Leu}{Tyr}{Ala}{Phe}{Gly}{Leu}-NH2

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Stay B, et al. The role of allatostatins in juvenile hormone synthesis in insects and crustaceans. Annu Rev Entomol. 2007;52:277-99.
molnova catalog
related products
  • Antho-Rfamide

    Antho-RFamide is a neuropeptide isolated from the sea anemone (Anthopleura elegantissima). Antho-RFamide contains a specific carboxyl-terminal sequence, Arg-Phe-NH2, that plays an important role in neural signaling. Antho-RFamide can be used to study the function of neuropeptides in the nervous system of the simplest animals.

  • HIV-1 TAT 48-60

    HIV-1 TAT (48-60) is a cell-penetrating peptide derived from the human immunodeficient virus (HIV)-1 Tat protein residue 48-60. This is one of the cell-penetrating peptides generated from the human immunodeficient virus -1 Tat protein residue 48-60.

  • PDE9-IN-1

    PDE9-IN-1 is a potent, selective, and orally bioavailable Inhibitor of phosphodiesterase-9A (PDE9A)(IC50 of 8.7 nM).